104 related articles for article (PubMed ID: 1237474)
1. Gaba blockade, dopamine and schizophrenia: experimental activation of the mesolimbic system.
Stevens JR
Int J Neurol; 1975; 10(1-4):115-27. PubMed ID: 1237474
[No Abstract] [Full Text] [Related]
2. Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity.
Benes FM
Biol Psychiatry; 1995 Dec; 38(12):783-7. PubMed ID: 8750035
[No Abstract] [Full Text] [Related]
3. Dopamine-acetylcholine-GABA neuronal linkages in the extrapyramidal and limbic systems.
McGeer PL; McGeer EG; Hattori T
Adv Biochem Psychopharmacol; 1977; 16():397-402. PubMed ID: 329651
[No Abstract] [Full Text] [Related]
4. Evidence for an inhibitory gabergic control of the meso-limbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs.
Fuxe K; Hökfelt T; Ljungdahl A; Agnati L; Johansson O; Perez de la Mora M
Med Biol; 1975 Jun; 53(3):177-83. PubMed ID: 1160412
[TBL] [Abstract][Full Text] [Related]
5. Some neuroactive compounds in the substantia nigra.
Krnjević K
Adv Neurol; 1974; 5():145-52. PubMed ID: 4155230
[No Abstract] [Full Text] [Related]
6. The dopamine hypothesis of schizophrenia revisited.
van Kammen DP
Psychoneuroendocrinology; 1979 Jan; 4(1):37-46. PubMed ID: 39306
[No Abstract] [Full Text] [Related]
7. Role of neostriatal and mesostriatal or mesolimbic dopaminergic fibres in Parkinson's disease with and without dementia: prospects, concepts and facts.
Cools AR
Yakubutsu Seishin Kodo; 1990 Mar; 10(1):15-34. PubMed ID: 2220127
[No Abstract] [Full Text] [Related]
8. Innervation of the substantia nigra.
Misgeld U
Cell Tissue Res; 2004 Oct; 318(1):107-14. PubMed ID: 15338269
[TBL] [Abstract][Full Text] [Related]
9. [Dopamine metabolism and the GABA level in the structures of the nigrostriatal and mesolimbic systems of the rat brain in experimental pathology of higher nervous activity].
Saul'skaia NB
Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(6):1145-51. PubMed ID: 3245325
[TBL] [Abstract][Full Text] [Related]
10. Neural circuitry models of schizophrenia: is it dopamine, GABA, glutamate, or something else?
Benes FM
Biol Psychiatry; 2009 Jun; 65(12):1003-5. PubMed ID: 19481640
[No Abstract] [Full Text] [Related]
11. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
Huot S; Lippert B; Palfreyman MG; Schechter PJ
Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
[No Abstract] [Full Text] [Related]
13. [Gamma-aminobutyric acid(GABA)--recent findings].
Saito K
Nihon Rinsho; 1978; 36(1):33-8. PubMed ID: 204812
[No Abstract] [Full Text] [Related]
14. [The role of the monoaminergic systems of the neostriatum and limbic structures in the pathology of higher nervous activity].
Suvorov NF
Vestn Akad Med Nauk SSSR; 1988; (11):42-9. PubMed ID: 2853499
[No Abstract] [Full Text] [Related]
15. Disinhibition as an organizing principle in the nervous system. The role of gamma-aminobutyric acid.
Roberts E
Adv Neurol; 1974; 5():127-43. PubMed ID: 4155229
[No Abstract] [Full Text] [Related]
16. The role of GABA in the basal ganglia and limbic system for behaviour.
Scheel-Krüger J; Magelund G; Olianas M
Adv Biochem Psychopharmacol; 1981; 29():23-36. PubMed ID: 7020365
[TBL] [Abstract][Full Text] [Related]
17. [Dopaminergic receptor activity and the evolution of schizophrenia].
Fodoreanu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1985; 30(2):131-4. PubMed ID: 2864729
[No Abstract] [Full Text] [Related]
18. [Correlations between chemical mediators (dopamine, serotonin, acetylcholine and gaba), muscular tone and rapidity of movement].
Hassler R
Rev Neurol (Paris); 1972 Jul; 127(1):51-63. PubMed ID: 4358575
[No Abstract] [Full Text] [Related]
19. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
20. GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
Stevens J; Wilson K; Foote W
Psychopharmacologia; 1974; 39(2):105-19. PubMed ID: 4155802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
